BSL4 Viruses: Understanding and Controlling Highly Infectious Pathogens
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 84
Special Issue Editor
Special Issue Information
Dear Colleagues,
The study of Biosafety Level 4 (BSL4) viruses represents a critical frontier in infectious disease research, demanding a comprehensive understanding of the molecular mechanisms underlying viral pathogenesis, transmission, and host immune responses. BSL4 viruses, classified as highly infectious and posing significant public health threats, include notorious pathogens such as Ebola virus, Marburg virus, Lassa virus, Junin virus, Machupo virus, Nipah, and Crimean-Congo hemorrhagic fever virus, among others.
This call for papers aims to bring together cutting-edge research focused on the interdisciplinary study of BSL4 viruses, encompassing virology, immunology, epidemiology, molecular biology, bioinformatics, and translational medicine. By elucidating viral life cycles and the complex interactions between BSL4 viruses and their hosts, researchers seek to uncover novel strategies for the prevention, detection, and treatment of these deadly pathogens.
Contributions to this Special Issue may cover a wide range of topics, including:
- Molecular mechanisms of BSL4 virus replication, transcription, and translation;
- Host–pathogen interactions and immune evasion strategies employed by BSL4 viruses;
- Epidemiology and surveillance of BSL4 virus outbreaks, including spatiotemporal dynamics and transmission routes;
- Development and evaluation of vaccines, therapeutics, and diagnostic tools for BSL4 virus infections;
- Animal models for studying BSL4 virus pathogenesis and evaluating candidate interventions;
- Genomic, transcriptomic, and proteomic analyses of BSL4 virus-host interactions;
- Evolutionary dynamics and emergence of novel BSL4 virus strains;
- Public health strategies for BSL4 virus containment, biosafety, and biosecurity.
We invite researchers from around the globe to submit original research articles, reviews, and perspectives that advance our biological understanding of BSL4 viruses and contribute to the development of effective countermeasures against these pathogens. Together, we wish to share the collective knowledge and expertise of the scientific community to address the urgent global health challenges posed by BSL4 viruses.
Prof. Dr. Slobodan Paessler
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hemorrhagic virus
- viral encephalitis
- vaccines
- viral therapies
- animal and tissue models
- diagnostics
- virus transmission
- systemic infections
